MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor report with the FDA on 2020-01-22 for NRG TRANSSEPTAL NEEDLE NRG-E-HF-71-C0 manufactured by Baylis Medical Company Inc..
[175921725]
Review of the device history record for the lot in question confirmed that all parts met manufacturing requirements prior to release. There is no evidence to suggest that the baylis medical device caused or contributed to the reported incident. However, as the baylis device was reported to be among the devices used in the procedure, baylis medical has decided to submit this report. There is no suspected device failure. The reported patient complication is an inherent risk in this type of procedure.
Patient Sequence No: 1, Text Type: N, H10
[175921726]
During an ablation procedure in which the nrg transseptal needle was used, a cardiac tamponade occurred. Following the procedure, the patient expired. During an ablation procedure for atrial fibrillation, an nrg transseptal needle was used for transseptal puncture. The patient's atrium was notably large and the physician had difficulty puncturing the septum. Transseptal puncture was achieved after four applications of rf energy using the rf needle. While the physician was manipulating a biosense webster ablation catheter in the patient's left atrium, the patient complained of a chest pain. After a blood pressure drop was observed, the patient had bradycardia and then cardiac arrest. The patient received intubation and cardiac massage, and subsequently underwent cardiac surgery. It was later reported that cardiac tamponade had been confirmed with bleeding observed from the posterior wall of the left atrium. The ablation procedure was aborted. The patient was hospitalized in a coronary care unit with the use of a percutaneous cardiopulmonary support system. Following the case on (b)(6) 2019, the patient expired on (b)(6) 2020. There is no evidence to suggest that a baylis medical device caused or contributed to the reported incident. However, as baylis medical device were reported to be among the devices used in the procedure, baylis medical has decided to submit this report.
Patient Sequence No: 1, Text Type: D, B5
| Report Number | 9710452-2020-00002 |
| MDR Report Key | 9617808 |
| Report Source | DISTRIBUTOR |
| Date Received | 2020-01-22 |
| Date of Report | 2020-01-22 |
| Date of Event | 2019-12-23 |
| Date Mfgr Received | 2019-12-26 |
| Date Added to Maude | 2020-01-22 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 3 |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 3 |
| Event Location | 3 |
| Manufacturer Contact | DR. MEGHAL KHAKHAR |
| Manufacturer Street | 2775 MATHESON BLVD. EAST |
| Manufacturer City | MISSISSAUGA, ONTARIO L4W 4P7 |
| Manufacturer Country | CA |
| Manufacturer Postal | L4W 4P7 |
| Manufacturer G1 | BAYLIS MEDICAL COMPANY INC. |
| Manufacturer Street | 2775 MATHESON BLVD. EAST |
| Manufacturer City | MISSISSAUGA, ONTARIO L4W 4P7 |
| Manufacturer Country | CA |
| Manufacturer Postal Code | L4W 4P7 |
| Single Use | 3 |
| Previous Use Code | 3 |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | NRG TRANSSEPTAL NEEDLE |
| Generic Name | RF TRANSSEPTAL NEEDLE |
| Product Code | DXF |
| Date Received | 2020-01-22 |
| Model Number | NRG-E-HF-71-C0 |
| Lot Number | NGFB220419 |
| Operator | HEALTH PROFESSIONAL |
| Device Availability | N |
| Device Eval'ed by Mfgr | R |
| Device Sequence No | 1 |
| Device Event Key | 0 |
| Manufacturer | BAYLIS MEDICAL COMPANY INC. |
| Manufacturer Address | 5959 TRANS-CANADA HIGHWAY MONTREAL, QUEBEC H4T 1A1 CA H4T 1A1 |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 1. Death | 2020-01-22 |